ArticleNature chemistry2026
A general strategy towards multicolour fluorogenic peptides for wash-free bioassays.
Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Peptide-based fluorescent probes are valuable tools for live-cell imaging, but conventional labelling approaches often require washing or long incubation, limiting their signal-to-noise ratios. Fluorogenic amino acids (FgAAs) can overcome these limitations, yet their rational design remains challenging owing to the lack of generalizable quenching principles and synthetic routes compatible with diverse fluorophores. Here we developed a general strategy to convert constitutively bright fluorophores into turn-on FgAAs through intramolecular tryptophan-induced quenching. Computational analysis showed that quenching is governed by photoinduced electron transfer or twisted intramolecular charge transfer mechanisms, with adaptability across ultraviolet-to-near-infrared fluorophore scaffolds. We synthesized a large library of multicolour FgAAs and integrated them into solid-phase peptide synthesis to generate turn-on probes for real-time microscopy in live cells. We then designed fluorogenic peptides targeting programmed cell death protein 1 (PD-1), enabling T cell targeted drug screening and identifying avasimibe as a small-molecule modulator of PD-1 activity. This work establishes a rational strategy for designing multicolour FgAAs for peptide engineering, imaging and drug discovery.
Identifiers
42649276What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.